BIO
Bio-Rad Laboratories Inc
NYSE: BIO · HEALTHCARE · MEDICAL DEVICES
$275.15
-1.50% today
Updated 2026-04-29
Market cap
$7.43B
P/E ratio
9.88
P/S ratio
2.88x
EPS (TTM)
$27.85
Dividend yield
—
52W range
$211 – $343
Volume
0.3M
Bio-Rad Laboratories Inc (BIO) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+25.2%
Last 4 quarters
Revenue YoY growth
+3.9%
Most recent quarter
EPS YoY growth
-13.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+0.4%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+13.8%
2025-07-31
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-12 | $2.51 | -7.4% | $293.69 | $256.56 | -12.6% |
| 2025-10-30 | $2.26 | +16.5% | $319.47 | $319.55 | +0.0% |
| 2025-07-31 | $2.61 | +49.1% | $250.08 | $284.60 | +13.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $2.71 | $2.51 | -7.4% | $693.20M | +3.9% |
| 2025-09-30 | $1.94 | $2.26 | +16.5% | $653.00M | +0.5% |
| 2025-06-30 | $1.75 | $2.61 | +49.1% | $651.60M | +2.1% |
| 2025-03-31 | $1.78 | $2.54 | +42.7% | $585.40M | -4.2% |
| 2024-12-31 | $2.88 | $2.90 | +0.7% | $667.48M | -2.0% |
| 2024-09-30 | $1.18 | $2.01 | +70.3% | $649.73M | +2.8% |
| 2024-06-30 | $2.01 | $3.11 | +54.7% | $638.48M | -6.3% |
| 2024-03-31 | $2.15 | $2.29 | +6.5% | $610.82M | — |
| 2023-12-31 | $2.82 | $3.10 | +9.9% | $681.18M | — |
| 2023-09-30 | $2.78 | $2.33 | -16.2% | $632.12M | — |
| 2023-06-30 | $2.68 | $3.00 | +11.9% | $681.11M | — |
Frequently asked questions
Has Bio-Rad Laboratories Inc beaten earnings estimates?
Bio-Rad Laboratories Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +25.2% over the last 4 quarters.
How does BIO stock react to earnings?
BIO stock has moved an average of +0.4% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Bio-Rad Laboratories Inc's revenue growth rate?
Bio-Rad Laboratories Inc reported year-over-year revenue growth of +3.9% in its most recent quarter, with EPS growing -13.4% year-over-year.